Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹1,771.20
295.20 (20.00%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹1.80K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
N/A
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹990.1+78.9%
52W High₹1,771.20.0%
Current Price
₹1,771.20
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹1,416.96
Upper Circuit₹2,125.44
Reference Price
₹1,771.20
Investment Checklist
3-day momentum: +16.3% — strong upward pressure
Triple Top on 1D — target ₹1364.5
Double Top on 1W — target ₹296.9
Trend: Price above all key MAs — strong uptrend
Volume divergence: Bearish (price up, volume down)
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
49%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend
EMA20
1451.09
EMA50
1383.18
Price Action
MIXED
NEUTRAL
Higher Highs5
Higher Lows5
Lower Highs4
Lower Lows4
Support & Resistance Levels
Resistance (Above)
No recent resistance detected
Support (Below)
₹1768.90
₹1677.22
₹1590.10
₹1512.20
₹1468.53
Volume Analysis
TrendDECREASING
Change-16.50%
Unusual Volume
Yes (5.78x avg)
Divergence Detected
Bearish (price up, volume down)
Recent MA Crossovers
20/50 Bullish Cross
5 days ago
BUY
Stop Loss Levels
Fixed Risk
1% Risk₹1753.49
3% Risk₹1718.06
5% Risk₹1682.64
7% Risk (Custom)
₹1647.22Technical Levels
1x ATR (Volatility)₹1676.57
2x ATR (Swing)₹1581.94
3x ATR (Trend)₹1487.31
Immediate Support₹1768.90
Moving Averages
EMA 9 (Short-term)₹1522.49
EMA 20 (Medium-term)₹1451.09
EMA 50 (Trend)₹1383.18
Financials
Financial Analysis
| Metric | Mar '22 | Mar '23 | Mar '24 | Mar '25 |
|---|---|---|---|---|
| Revenue | ₹183.8 Cr | ₹227.1 Cr | ₹295.7 Cr | ₹362.4 Cr |
| Net Profit | ₹24.8 Cr | ₹30.7 Cr | ₹36.4 Cr | ₹42.4 Cr |
| EPS | ₹24.59 | ₹30.43 | ₹37.90 | ₹42.02 |
| Operating Profit | ₹43.3 Cr | ₹53.7 Cr | ₹61.2 Cr | ₹76.2 Cr |
ROE
21.52%
ROCE
19.01%
Debt/Equity
0.70
Current Ratio
3.22
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 23 Sept 2024 | ANNUAL GENERAL MEETING | AGM |
| 22 Sept 2023 | ANNUAL GENERAL MEETING | AGM |
| 20 Sept 2022 | ANNUAL GENERAL MEETING | AGM |
| 21 Sept 2021 | ANNUAL GENERAL MEETING | AGM |
| 21 Sept 2020 | ANNUAL GENERAL MEETING | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for BETA
View All
positive
Business Standard - Markets 3d ago
Sebi may widen 50% overlap rule to thematic passive mutual fund schemes
Curb on number of smart-beta schemes also likely; move aimed at curbing proliferation in segment
ABSLPSEALPHAALPHAETFAONEGOLDAONELIQUIDAONENIFTYAONESILVERAONETOTALAUTOBEESAUTOIETFAXISBNKETFAXISBPSETFAXISCETFAXISGOLDAXISHCETFAXISILVERAXISNIFTYAXISTECETFAXISVALUEAXSENSEXBANK10ADDBANKADDBANKBETFBANKETFBANKPSUBBETF0432BBNPNBETFBBNPPGOLDBETABFSICHEMICALCHOICEGOLDCOMMOIETFDEFENCEDIVIDENDEBANKNIFTYEBBETF0430EBBETF0431EBBETF0433ECAPINSUREEGOLDELIQUIDELM250ENERGYENIFTYEQUAL200EQUAL50EQUAL50ADDESENSEXESGESILVERFINIETFFLEXIADDFMCGADDFMCGIETFGILT10BETAGILT5BETAGOLD1GOLD360GOLDADDGOLDBETAGOLDBNDGOLDETFGROWWCAPMGROWWCHEMGROWWDEFNCGROWWEVGROWWGOLDGROWWHOSPIGROWWLIQIDGROWWLOVOLGROWWMC150GROWWMETALGROWWMOM50GROWWN200GROWWNETGROWWNIFTYGROWWNXT50GROWWPOWERGROWWPSEGROWWPSUBKGROWWRAILGROWWRLTYGROWWSC250GROWWSLVRGSEC10IETFGSEC10YEARHDFCGOLDHDFCGROWTHHDFCLOWVOLHDFCMID150HDFCMOMENTHDFCNEXT50HDFCNIF100HDFCNIFITHDFCPSUBKHDFCPVTBANHDFCQUALHDFCSILVERHDFCSML250HDFCVALUEHEALTHADDHEALTHCAREHEALTHIETFHSBCGOLDICICIB22INFRAIETFINTERNETITADDITBEESITBETAITETFITIETFLICNETFSENLICNMID100LIQGRWBEESLIQUIDLIQUID1LIQUIDPLUSLIQUIDSBILIQUIDSHRILOWVOLMAFANGMAHKTECHMAKEINDIAMANUFGBEESMASPTOP50METALMETALIETFMID150MIDCAPADDMIDCAPBETAMIDCAPETFMIDCAPIETFMIDQ50ADDMNCMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM30IETFMOM50MOMENTUMMOMENTUM30MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTOURMOVALUEMSCIADDMSCIINDIAMULTICAPNEXT30ADDNEXT50NEXT50ADDNEXT50BETANEXT50ETFNEXT50IETFNIFTY100EWNIFTYADDNIFTYBETFNIFTYETFNIFTYQLITYOILIETFPHARMABEESPSUBANKADDPSUBNKIETFPVTBANKADDQUALITY30SBIBPBSBIETFCONSBIETFITSBIETFPBSBIETFQLTYSBILIQETFSBINEQWETFSBINMID150SBISILVERSELECTIPOSENSEXETFSETF10GILTSILVERSILVER1SILVER360SILVERADDSILVERAGSILVERBEESSILVERBETASILVERBNDSILVERIETFSMALL250SMALLADDSNXT30BEESTATAGOLDTATSILVTECHTNIDETFTOP10ADDTOP20TWCGOLDETFUNIONGOLDVAL30IETFVALUEFinancial ServicesHealthcare
negative
ET Markets - Stocks 10d ago
TCS Share Price Live Updates: TCS's beta of 0.4044 highlights low market risk
BETATCSHealthcareInformation Technology
positive
ET Markets - Stocks 10d ago
Bharti Airtel Share Price Live Updates: Bharti Airtel's Beta Value Explained
BETABHARTIARTLVALUEFinancial ServicesHealthcare